Arkolith/Insider Trading/VRPX/Form 4

Sendrow Jerrold

DirectorVirpax Pharmaceuticals, Inc. (VRPX) · full profile →Form 4 · filed Nov 24, 2021
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2021Buy(P)4K$3.93$15K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-001536) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML